| 1 |
Hummel S, Van Aken H, Zarbock A. Inhibitors of CXC chemokine receptor type 4: putative therapeutic approaches in inflammatory diseases[J]. Curr Opin Hematol, 2014, 21 (1): 29-36.
URL
|
| 2 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810.
|
| 3 |
Zhou J, Tian H, Du X, et al. Population-based epidemiology of sepsis in a subdistrict of Beijing[J]. Crit Care Med, 2017, 45 (7): 1168-1176.
|
| 4 |
黄颖，寿松涛，王军，等. 脓毒症与免疫细胞凋亡相关研究进展[J/CD]. 中华危重症医学杂志（电子版），2017，10(4):270-273.
URL
|
| 5 |
Peng D, Cao B, Zhou YJ, et al. The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential[J]. Eur J Med Chem, 2018 (149): 148-169.
|
| 6 |
Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR / fusin and prevents infection by T-cell-line-adapted HIV-1[J]. Nature, 1996, 382 (6594): 833-835.
|
| 7 |
Pozzobon T, Goldoni G, Viola A, et al. CXCR4 signaling in health and disease[J]. Immunol Lett, 2016 (177): 6-15.
|
| 8 |
Pawig L, Klasen C, Weber C, et al. Diversity and inter-connections in the CXCR4 chemokine receptor / ligand family: molecular perspectives[J]. Front Immunol, 2015 (6): 429.
|
| 9 |
Neptune ER, Bourne HR. Receptors induce chemotaxis by releasing the βγ subunit of Gi, not by activating Gq or Gs[J]. Proc Natl Acad Sci U S A, 1997, 94 (26): 14489-14494.
|
| 10 |
Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back[J]. Science, 2003, 302 (5651): 1704-1709.
|
| 11 |
Baggiolini M. Chemokines and leukocyte traffic[J]. Nature, 1998, 392 (6676): 565-568.
|
| 12 |
Paredes-Zúniga S, Morales RA, Munoz-Sánchez S, et al. CXCL12a / CXCR4b acts to retain neutrophils in caudal hematopoietic tissue and to antagonize recruitment to an injury site in the zebrafish larva[J]. Immunogenetics, 2017, 69 (5): 341-349.
|
| 13 |
Delano MJ, Kelly-Scumpia KM, Thayer TC, et al. Neutrophil mobilization from the bone marrow during polymicrobial sepsis is dependent on CXCL12 signaling[J]. J Immunol, 2011, 187 (2): 911-918.
|
| 14 |
Isaacson B, Hadad T, Glasner A, et al. Stromal cell-derived factor 1 mediates immune cell attraction upon urinary tract infection[J]. Cell Rep, 2017, 20 (1): 40-47.
|
| 15 |
Petrie Aronin CE, Zhao YM, Yoon JS, et al. Migrating myeloid cells sense temporal dynamics of chemoattractant concentrations[J]. Immunity, 2017, 47 (5): 862-874.e3.
|
| 16 |
Hirano Y, Ode Y, Ochani M, et al. Targeting junctional adhesion molecule-C ameliorates sepsis-induced acute lung injury by decreasing CXCR4+ aged neutrophils[J]. J Leukoc Biol, 2018, 104 (6): 1159-1171.
|
| 17 |
Lelubre C, Vincent JL. Mechanisms and treatment of organ failure in sepsis[J]. Nat Rev Nephrol, 2018, 14 (7): 417-427.
|
| 18 |
De Filippo K, Rankin SM. CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease[J]. Eur J Clin Invest, 2018, 48 (Suppl 2): e12949.
|
| 19 |
Hampton HR, Bailey J, Tomura M, et al. Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes[J]. Nat Commun, 2015 (6): 7139.
|
| 20 |
Lim K, Hyun Y, Lambert-Emo K, et al. Neutrophil trails guide influenza-specific CD8+ T cells in the airways[J]. Science, 2015, 349 (6252): aaa4352.
|
| 21 |
Ramonell KM, Zhang W, Hadley A, et al. CXCR4 blockade decreases CD4+ T cell exhaustion and improves survival in a murine model of polymicrobial sepsis[J]. PLoS One, 2017, 12 (12): e0188882.
|
| 22 |
Badr HS, El-Gendy FM, Helwa MA. Serum stromal-derived-factor-1 (CXCL12) and its alpha chemokine receptor (CXCR4) as biomarkers in neonatal sepsis[J]. J Matern Fetal Neonatal Med, 2018, 31 (16): 2209-2215.
|
| 23 |
刘姗. 抑制性中性粒细胞亚群通过CXCR4增强老龄脓毒症群体Treg细胞免疫抑制作用[D]. 大连：大连医科大学，2017.
|
| 24 |
Tunc T, Cekmez F, Cetinkaya M, et al. Diagnostic value of elevated CXCR4 and CXCL12 in neonatal sepsis[J]. J Matern Fetal Neonatal Med, 2015, 28 (3): 356-361.
|
| 25 |
Franchini S, Marcianò T, Sorlini C, et al. Serum CXCL12 levels on hospital admission predict mortality in patients with severe sepsis / septic shock[J]. Am J Emerg Med, 2015, 33 (12): 1802-1804.
|
| 26 |
Wang X, Zhang AQ, Gu W, et al. Clinical relevance of single nucleotide polymorphisms in the CXCL1 and CXCL12 genes in patients with major trauma[J]. J Trauma Acute Care Surg, 2019, 86 (3): 440-447.
|
| 27 |
Seemann S, Lupp A. Administration of a CXCL12 analog in endotoxemia is associated with anti-inflammatory, anti-oxidative and cytoprotective effects in vivo[J]. PLoS One, 2015, 10 (9): e0138389.
|
| 28 |
李育明. 脓毒症免疫功能及其生物标志物研究进展[J]. 中国急救医学，2017，37(2):119-122.
|
| 29 |
Zhou Y, Li P, Goodwin AJ, et al. Exosomes from endothelial progenitor cells improve the outcome of a murine model of sepsis[J]. Mol Ther, 2018, 26 (5): 1375-1384.
|
| 30 |
Fan H, Goodwin AJ, Chang E, et al. Endothelial progenitor cells and a stromal cell-derived factor-1α analogue synergistically improve survival in sepsis[J]. Am J Respir Crit Care Med, 2014, 189 (12): 1509-1519.
|
| 31 |
Witzenrath M. Endothelial progenitor cells for acute respiratory distress syndrome treatment: support your local sheriff![J]. Am J Respir Crit Care Med, 2014, 189 (12): 1452-1455.
|